Search

everythinglearnresearchcommunity

for

Search:↓

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

A Cavalier King Charles Spaniel had both uveodermatological syndrome and alopecia areata, and treatment with ciclosporin helped regrow hair.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Ciclosporin A effectively treated a cat's severe skin condition.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Strong skin creams work well for long-term scalp inflammation in Rapp-Hodgkin Ectodermal Dysplasia.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Two mouse mutations cause similar hair loss despite different skin changes.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A young man was initially misdiagnosed with a scalp condition but was found to have a fungal infection, which improved with antifungal treatment.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.